Skip to content
DraconiticResearch
Search Sources API
216,686 studies31 sourcesUpdated 23 min ago

Oncology

5,539 studies453 in 7 days2,591 in 30 days

Filters
Type
Date
Clear

Latest

5,539 studies

  1. MRI Features of Diffuse Glioneuronal Tumor with Oligodendroglioma-like features and Nuclear Clusters: A Case Report and Literature Review
    Dabiao Deng, Chongzhu Fan, Yanying Yang +3
    Current Medical ImagingPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Non-malignant breast cancer-related breast edema: an overview
    Emily Deehan, Rayya Harb, Harvey Mayrovitz
    Translational Breast Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  3. Multi-Modal Kinome Profiling Discovers Mesenchymal-Like Polarity Networks that Underly Directed Hepatocellular Carcinoma Cell Migration
    T. A. Rantso, K. Woods, P. Jensen +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Preclinical evaluation of ixazomib for high-risk pediatric brain tumors
    E. Janko, F. M. Walker, M. Slade +10
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  5. Rac1 and CHK1 Converge on Abi-1 to Regulate DNA Repair Dependency and Treatment Response in Human Cancers
    Y. Huang, E. McCulla, J. Park +27
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  6. Inverted logic of ecDNA localization converts nuclear periphery into oncogenic transcription hubs in cancer
    Y. Wang, X. Yan, N. E. Weiser +16
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  7. Na+/K+-ATPase Blockade Reversibly Attenuates Proliferation and Metabolic Function in K562 Human Myelogenous Leukemia Cells
    S. R. Bowden, E. T. Colton, A. D. Norgaard +13
    bioRxivPreprintCC BYFull textOncologybioRxiv
  8. A mechanistic digital twin model for epigenetic therapy optimization in triple-negative breast cancer
    S. Bruno, A. Indeglia, S. Lichterfeld +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  9. A therapeutic vulnerability linking MNK1/2 inhibition and G1/S cyclin-dependent kinase blockade in triple-negative breast cancer
    Q. Deng, M. Amiri, A. Moshari +11
    bioRxivPreprintCC BYFull textOncologybioRxiv
  10. ZNF217 promotes receptor tyrosine kinase plasticity and AXL-ERK dependency in ovarian cancer
    M. J. Pandya, J. Hoffman, A. Padmanabhan
    bioRxivPreprintCC BYFull textOncologybioRxiv
  11. DDRKOL: A Focused CRISPR Library for Systematic Identification of DNA Damage Response Dependencies in Glioblastoma
    C. Bayraktar-Odabas, I. Kok, A. Ozbiyik +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  12. FKBP9 Drives Hepatocellular Carcinoma EMT by Regulating SEPT6 Transcription and Stability to Activate TGF-β Signaling.
    Yu Zhang, Rixin Su, Jie Zou +4
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  13. CST1 Regulates ER-Mitochondrial Mg²⁺ Balance via MAGT1 to Promote Breast Cancer Metabolism and Growth.
    Wenqiang Gan, Min Zheng, Li Liu +8
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  14. Exon-6 truncated p53 Suppresses Innate Immune Responses to Facilitate Immune Evasion in Bladder Cancer.
    Chi Zhang, Wenjie Wei, Senming Cao +13
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  15. Targeting NCAPG with Arundanine Suppresses Neutrophil/NET-Mediated Immune Evasion and Enhances CD8⁺ T Cell Function in Lung Squamous Cell Carcinoma.
    Xuyu Gu, Dongning Lu, Ming Deng +4
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  16. Glycovariants of CA-125 in the early detection of ovarian cancer
    A. J. Vickers, O. Melander, K. Long Roche +6
    medRxivPreprintPublic domainFull textOncologymedRxiv
  17. Dosimetric Impact of Residual Intrafraction Motion in Gated MR-Guided Prostate SBRT With Focal Dose Intensification
    K. H. Tam, S. Jogi, A. Sobremonte +17
    medRxivPreprintCC BYFull textOncologymedRxiv
  18. The ''Hamburg Life After Cancer Program'': Development, Implementation and Evaluation of a Structured Survivorship Program - Study Protocol of a Hybrid Effectiveness-Implementation Study
    H. Führes, J. von Grundherr, F. Wolters +10
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  19. Explainable machine learning for breast cancer prediction in resource-constrained settings: A multi-algorithmic framework integrating shap-based transparency with clinical decision support
    Oluwaseun Adebayo Bamodu, Sumaiya Nezam, Chen-Chih Chung
    PLOS Digital HealthPeer-reviewedCC BY 4.0Full textOncologyPLOS
  20. Stage-specific evolutionary dynamics in pediatric leukemia inferred using Bayesian stochastic modeling
    Seung-Hwan Kim
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  21. Rates of childbirth in female cancer survivors: A population-based study in Taiwan
    Ya-Ling Hsieh, Chia-Jung Chiang, Tsung Yu
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  22. Burden of malignant melanoma among the elderly population in East Asia from 1990 to 2023 and machine learning projection to 2040
    Qian Liu, Jianfeng Ma, Hao Yang +5
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOS
  23. Construction of an experimental set up to perform full body micro cannulations of sub-millimetric vessels in an anatomical research setting
    Michael E. J. Stouthandel, Danial Forouhar, Charlotte Debbaut +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologySurgery & anaesthesiaPLOS
  24. Computational surveillance of Colombian public pharmaceutical procurement using public administrative data: A reproducible analysis of a closed 2020–2025 cohort
    Andrés Soto
    PLOS OnePeer-reviewedCC BY 4.0OncologyPharmacology & toxicologyPLOS
  25. Impact of menopausal status on human papillomavirus detection and cervical neoplasia in middle-aged Senegalese women
    Emily R. Spencer, Rachel L. Winer, Selly Ba +7
    PLOS OnePeer-reviewedCC BY 4.0Full textInfectious diseaseOncologyPLOS